Cargando…
Unveiling a Biomarker Signature of Meningioma: The Need for a Panel of Genomic, Epigenetic, Proteomic, and RNA Biomarkers to Advance Diagnosis and Prognosis
SIMPLE SUMMARY: MRI and histological assessment remain the gold standard for meningioma diagnosis. Currently, WHO grading of meningiomas mainly depends on histologic and morphological markers and two molecular markers. WHO grading can reliably diagnose meningiomas in most cases. However, it was not...
Autores principales: | Halabi, Reem, Dakroub, Fatima, Haider, Mohammad Z., Patel, Stuti, Amhaz, Nayef A., Reslan, Mohammad A., Eid, Ali H., Mechref, Yehia, Darwiche, Nadine, Kobeissy, Firas, Omeis, Ibrahim, Shaito, Abdullah A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10670806/ https://www.ncbi.nlm.nih.gov/pubmed/38001599 http://dx.doi.org/10.3390/cancers15225339 |
Ejemplares similares
-
Acute ischemic stroke biomarkers: a new era with diagnostic promise?
por: Bsat, Shadi, et al.
Publicado: (2021) -
The Antitumor Effect of the DNA Polymerase Alpha Inhibitor ST1926 in Glioblastoma: A Proteomics Approach
por: El-Baba, Chirine, et al.
Publicado: (2023) -
Searching for Novel Candidate Biomarkers of RLS in Blood by Proteomic Analysis
por: Mondello, Stefania, et al.
Publicado: (2021) -
MS-based glycomics: An analytical tool to assess nervous system diseases
por: Peng, Wenjing, et al.
Publicado: (2022) -
LC-MS/MS-Based Proteomics Approach for the Identification of Candidate Serum Biomarkers in Patients with Narcolepsy Type 1
por: Sanni, Akeem, et al.
Publicado: (2023)